202 related articles for article (PubMed ID: 19909464)
21. Outcome analysis of patients requiring mechanical ventilation with severe community-acquired pneumonia and identified bacterial pathogens.
Hu HC; Huang CC; Tsai YH; Lee CH; Hsieh MJ
Chang Gung Med J; 2005 Apr; 28(4):229-36. PubMed ID: 16013342
[TBL] [Abstract][Full Text] [Related]
22. [Severe community-acquired pneumonia due to Acinetobacter baumannii].
Tanaka M; Asada M; Kanda A; Okazaki K; Inomata S; Akiu N; Ebihara S
Nihon Kokyuki Gakkai Zasshi; 2011 Oct; 49(10):760-4. PubMed ID: 22117314
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
Bodí M; Rodríguez A; Solé-Violán J; Gilavert MC; Garnacho J; Blanquer J; Jimenez J; de la Torre MV; Sirvent JM; Almirall J; Doblas A; Badía JR; García F; Mendia A; Jordá R; Bobillo F; Vallés J; Broch MJ; Carrasco N; Herranz MA; Rello J;
Clin Infect Dis; 2005 Dec; 41(12):1709-16. PubMed ID: 16288392
[TBL] [Abstract][Full Text] [Related]
24. Impact of pandemic influenza (H1N1) virus-associated community-acquired pneumonia among adults in a tertiary hospital in Thailand.
Champunot R; Tanjatham S; Kerdsin A; Puangpatra P; Wangsai S; Treebuphachatsakul P; Tasnsuphaswasdikul S; Kiatvitchukul C; Kasyanan H; Yimsabai J; Akeda Y; Kawakami K; Sawanpanyalert P; Dejsirilert S; Oishi K
Jpn J Infect Dis; 2010 Jul; 63(4):251-6. PubMed ID: 20657064
[TBL] [Abstract][Full Text] [Related]
25. Mortality risk factors of Acinetobacter baumannii bacteraemia.
Choi JY; Park YS; Kim CO; Park YS; Yoon HJ; Shin SY; Kim YA; Song YG; Yong D; Lee K; Kim JM
Intern Med J; 2005 Oct; 35(10):599-603. PubMed ID: 16207259
[TBL] [Abstract][Full Text] [Related]
26. Fulminant community-acquired pneumonia probably caused by Acinetobacter lwoffii.
Toyoshima M; Chida K; Suda T
Respirology; 2010 Jul; 15(5):867-8. PubMed ID: 20546186
[TBL] [Abstract][Full Text] [Related]
27. Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.
Tejerina E; Frutos-Vivar F; Restrepo MI; Anzueto A; Palizas F; González M; Apezteguía C; Abroug F; Matamis D; Bugedo G; Esteban A;
J Crit Care; 2005 Sep; 20(3):230-8. PubMed ID: 16253791
[TBL] [Abstract][Full Text] [Related]
28. Severe community acquired pneumonia: a one-year analysis in a tertiary referral intensive care unit.
Gowardman J; Trent L
N Z Med J; 2000 May; 113(1109):161-4. PubMed ID: 10894342
[TBL] [Abstract][Full Text] [Related]
29. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.
Kontou P; Kuti JL; Nicolau DP
Am J Emerg Med; 2009 Oct; 27(8):968-74. PubMed ID: 19857416
[TBL] [Abstract][Full Text] [Related]
30. Emergence of resistant Acinetobacter baumannii in critically ill patients within an acute care teaching hospital and a long-term acute care hospital.
Stephens C; Francis SJ; Abell V; DiPersio JR; Wells P
Am J Infect Control; 2007 May; 35(4):212-5. PubMed ID: 17482991
[TBL] [Abstract][Full Text] [Related]
31. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
[TBL] [Abstract][Full Text] [Related]
32. Severe community-acquired pneumonia requiring intensive care: a study of 80 cases from Singapore.
Poulose V
Singapore Med J; 2008 Jun; 49(6):458-61. PubMed ID: 18581017
[TBL] [Abstract][Full Text] [Related]
33. Etiologies and treatment outcomes in patients hospitalized with community-acquired pneumonia (CAP) at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W; Lulitanond V; Tantiwong P; Saelee R; Pisprasert V
Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):156-61. PubMed ID: 15906660
[TBL] [Abstract][Full Text] [Related]
34. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.
Wroblewska MM; Towner KJ; Marchel H; Luczak M
Clin Microbiol Infect; 2007 May; 13(5):490-6. PubMed ID: 17331123
[TBL] [Abstract][Full Text] [Related]
35. Emergence of multidrug-resistant isolates of Acinetobacter baumannii.
Okpara AU; Maswoswe JJ
Am J Hosp Pharm; 1994 Nov; 51(21):2671-5. PubMed ID: 7856578
[TBL] [Abstract][Full Text] [Related]
36. Acinetobacter baumannii: an emerging multidrug-resistant threat.
Gootz TD; Marra A
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
[TBL] [Abstract][Full Text] [Related]
37. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.
Holloway KP; Rouphael NG; Wells JB; King MD; Blumberg HM
Ann Pharmacother; 2006 Nov; 40(11):1939-45. PubMed ID: 17018688
[TBL] [Abstract][Full Text] [Related]
38. [Bacteremia caused by Acinetobacter baumannii among patients in critical care].
Aguirre-Avalos G; Mijangos-Méndez JC; Zavala-Silva ML; Coronado-Magaña H; Amaya-Tapia G
Gac Med Mex; 2009; 145(1):21-5. PubMed ID: 19256407
[TBL] [Abstract][Full Text] [Related]
39. [Epidemiology, clinical aspects and prognosis of severe progressive community-acquired pneumonia].
Höltermann W; Krämer M; Geppert P; van Wickern M; Lukasewitz P
Pneumologie; 1998 May; 52(5):263-70. PubMed ID: 9654975
[TBL] [Abstract][Full Text] [Related]
40. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
